News
CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...
Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...
Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...
Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...
BioNTech stock was rising after the drugmaker reported better-than-expected results on Monday. In early trading, the ...
The company expects that the U.S. COVID-19 vaccination rate will be “maybe a couple of points lower” than the prior level of ...
3d
The Manila Times on MSNPfizer and BioNTech lose UK court appeal over Covid-19 jabPfizer says it will appeal the Aug 1 ruling to Britain’s Supreme Court. Read more at straitstimes.com. Read more at ...
BioNTech SE BNTX +3.21% Get Free Report reported a second-quarter per-share loss of $1.82 (1.60 euros) on Monday, up from a loss of 3.36 euros reported a year ago, compared to beating the consensus ...
A U.K. Court of Appeals ruling confirms the validity of a patent covering modifications of mRNA used in Moderna’s vaccines.
15d
TheHealthSite on MSNPfizer-BioNTech's COVID-19 Vaccine: What Does A Thicker Cornea And Reduced Cell Density Mean?BioNTech's COVID-19 vaccine on one's eye, which could lead an indivual to permanent vision loss. Read on... TheHealthSite.com ...
Pfizer should have different top-selling drugs in 2030 with a heavier focus on oncology. The drugmaker should be more ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results